Development and validation of chest CT-based imaging biomarkers for early stage COVID-19 screening

Coronavirus Disease 2019 (COVID-19) is currently a global pandemic, and early screening is one of the key factors for COVID-19 control and treatment. Here, we developed and validated chest CT-based imaging biomarkers for COVID-19 patient screening from two independent hospitals with 419 patients. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiao-Ping, Yang, Xu, Xiong, Miao, Mao, Xuanyu, Jin, Xiaoqing, Li, Zhiqiang, Zhou, Shuang, Chang, Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533142/
https://www.ncbi.nlm.nih.gov/pubmed/36211676
http://dx.doi.org/10.3389/fpubh.2022.1004117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533142/
https://www.ncbi.nlm.nih.gov/pubmed/36211676
http://dx.doi.org/10.3389/fpubh.2022.1004117

Ejemplares similares